Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Concomitant Regimen vs High Dose Dual Therapy for H. Pylori Rescue
NCT01265069Phase 4Unknown
- Sponsor
- National Taiwan University Hospital
- Start
- Nov 2010
- Primary completion
- Jun 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of rabeprazole, amoxicillin, metronidazole, clarithromycin in Helicobacter pylori infection, sponsored by National Taiwan University Hospital. Status: unknown.
02
Drugs
rabeprazoleamoxicillinmetronidazoleclarithromycin
03
Conditions
Helicobacter pylori infection
Beyond the preview
Go deeper on NCT01265069.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01265069.